InvestorsHub Logo
Followers 42
Posts 5093
Boards Moderated 0
Alias Born 05/10/2012

Re: None

Thursday, 07/19/2012 1:31:57 PM

Thursday, July 19, 2012 1:31:57 PM

Post# of 7490
Avita and China

So it's expected that Avita will begin to generate sales in China in the 4th quarter of this year. I think it is safe to assume that with no competing products on the market Avita stands a good chance of meeting their targeted sales. I believe some savvy Chinese investors will take notice of this new product in their country and perhaps buy on our exchange.

Avita

Clipped from the link above :

Dr William Dolphin, CEO of Avita Medical, said, “China is a massive and highly attractive market for the
company’s products. ReCell addresses the growing demand for cosmetic surgery, scar revision and the
treatment of burns and chronic wounds. The product is being targeted to China’s burgeoning middle
class, a rapidly growing segment of the country’s 1.3 billion people. With SFDA approval in place, the
Company is focused on obtaining pricing approval and introducing ReCell to China’s key surgeons and
clinicians. We are garnering significant support from influential Chinese surgeons and making steady
progress toward our goal of commercial launch in 4Q 2012.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RCEL News